Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony A Matthews

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Open Forum Infectious Diseases|August 26, 2024
Comparative Effectiveness of Switching to Bictegravir From Dolutegravir-, Efavirenz-, or Raltegravir-Based Antiretroviral Therapy Among Individuals With HIV Who are Virologically SuppressedIsaac Núñez, Yanink Caro-Vega, Conor MacDonald, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 5, 2021
Risk of Cardiovascular Diseases Among Older Breast Cancer Survivors in the United States: A Matched Cohort StudyAnthony A Matthews, Sharon Peacock Hinton, Susannah Stanway, et al.
Heart (British Cardiac Society)|November 12, 2020
Endocrine therapy use and cardiovascular risk in postmenopausal breast cancer survivorsAnthony A Matthews, Sharon Peacock Hinton, Susannah Stanway, et al.
Journal of Global Health|March 21, 2025
The target trial framework in global health research: barriers and opportunitiesAli Al-Kassab-Córdova, Esteban A Alarcón-Braga, Camila Olarte Parra, et al.
Pharmacoepidemiology and Drug Safety|December 3, 2025
Cardiovascular Effectiveness of Semaglutide Versus Dulaglutide in Type 2 DiabetesKasper Bonnesen, Uffe Heide-Jørgensen, Diana H Christensen, et al.
Journal of the American Heart Association|May 17, 2021
Comparing Effect Estimates in Randomized Trials and Observational Studies From the Same Population: An Application to Percutaneous Coronary InterventionAnthony A Matthews, Karolina Szummer, Issa J Dahabreh, et al.
American Journal of Epidemiology|May 31, 2022
Benchmarking Observational Analyses Before Using Them to Address Questions Trials Do Not Answer: An Application to Coronary Thrombus AspirationAnthony A Matthews, Issa J Dahabreh, Ole Fröbert, et al.
Epidemiology (Cambridge, Mass.)|May 4, 2026
Extending inferences from a randomized trial to trial-eligible and treatment-candidate target populations: examples of generalizability and transportabilityJessica C Young, Issa J Dahabreh, Stefan James, et al.
JACC. Cardiooncology|May 2, 2022
Does Cardiovascular Mortality Overtake Cancer Mortality During Cancer Survivorship?: An English Retrospective Cohort StudyHelen Strongman, Sarah Gadd, Anthony A Matthews, et al.
Annals of Epidemiology|June 12, 2025
The definition of treatment assignment in observational emulations of target trials - an empirical examination in the Swedish Primary Care Cardiovascular DatabaseAnna B C Humphreys, Anthony A Matthews, Jessica Young, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Open Forum Infectious Diseases|August 26, 2024
Comparative Effectiveness of Switching to Bictegravir From Dolutegravir-, Efavirenz-, or Raltegravir-Based Antiretroviral Therapy Among Individuals With HIV Who are Virologically SuppressedIsaac Núñez, Yanink Caro-Vega, Conor MacDonald, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 5, 2021
Risk of Cardiovascular Diseases Among Older Breast Cancer Survivors in the United States: A Matched Cohort StudyAnthony A Matthews, Sharon Peacock Hinton, Susannah Stanway, et al.
Heart (British Cardiac Society)|November 12, 2020
Endocrine therapy use and cardiovascular risk in postmenopausal breast cancer survivorsAnthony A Matthews, Sharon Peacock Hinton, Susannah Stanway, et al.
Journal of Global Health|March 21, 2025
The target trial framework in global health research: barriers and opportunitiesAli Al-Kassab-Córdova, Esteban A Alarcón-Braga, Camila Olarte Parra, et al.
Pharmacoepidemiology and Drug Safety|December 3, 2025
Cardiovascular Effectiveness of Semaglutide Versus Dulaglutide in Type 2 DiabetesKasper Bonnesen, Uffe Heide-Jørgensen, Diana H Christensen, et al.
Journal of the American Heart Association|May 17, 2021
Comparing Effect Estimates in Randomized Trials and Observational Studies From the Same Population: An Application to Percutaneous Coronary InterventionAnthony A Matthews, Karolina Szummer, Issa J Dahabreh, et al.
American Journal of Epidemiology|May 31, 2022
Benchmarking Observational Analyses Before Using Them to Address Questions Trials Do Not Answer: An Application to Coronary Thrombus AspirationAnthony A Matthews, Issa J Dahabreh, Ole Fröbert, et al.
Epidemiology (Cambridge, Mass.)|May 4, 2026
Extending inferences from a randomized trial to trial-eligible and treatment-candidate target populations: examples of generalizability and transportabilityJessica C Young, Issa J Dahabreh, Stefan James, et al.
JACC. Cardiooncology|May 2, 2022
Does Cardiovascular Mortality Overtake Cancer Mortality During Cancer Survivorship?: An English Retrospective Cohort StudyHelen Strongman, Sarah Gadd, Anthony A Matthews, et al.
Annals of Epidemiology|June 12, 2025
The definition of treatment assignment in observational emulations of target trials - an empirical examination in the Swedish Primary Care Cardiovascular DatabaseAnna B C Humphreys, Anthony A Matthews, Jessica Young, et al.
Pageof 3